Fresenius Medical Care (NYSE:FMS) Shares Gap Down – What’s Next?

Fresenius Medical Care AG (NYSE:FMS) shares gapped down before the market opened on Friday . The stock had previously closed at $24.25, but opened at $23.44. Fresenius Medical Care shares last traded at $23.43, with a volume of 113,904 shares trading hands.

Analyst Ratings Changes

A number of brokerages recently weighed in on FMS. Truist Financial lifted their price objective on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Monday, January 6th. StockNews.com upgraded shares of Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th. Berenberg Bank assumed coverage on Fresenius Medical Care in a report on Wednesday, November 6th. They set a “buy” rating and a $25.60 target price on the stock. Finally, Bank of America raised Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research note on Monday, December 2nd.

Fresenius Medical Care Stock Performance

The company’s 50-day moving average price is $23.46 and its two-hundred day moving average price is $21.51. The company has a market cap of $13.76 billion, a P/E ratio of 19.38, a price-to-earnings-growth ratio of 0.80 and a beta of 0.93. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of FMS. AQR Capital Management LLC acquired a new position in shares of Fresenius Medical Care in the 2nd quarter worth $197,000. Blue Trust Inc. increased its stake in Fresenius Medical Care by 1,060.9% in the 3rd quarter. Blue Trust Inc. now owns 12,863 shares of the company’s stock worth $274,000 after purchasing an additional 11,755 shares in the last quarter. Castleview Partners LLC lifted its stake in Fresenius Medical Care by 35.9% during the third quarter. Castleview Partners LLC now owns 17,286 shares of the company’s stock valued at $368,000 after buying an additional 4,571 shares in the last quarter. Riverwater Partners LLC boosted its holdings in shares of Fresenius Medical Care by 29.5% in the third quarter. Riverwater Partners LLC now owns 16,381 shares of the company’s stock worth $346,000 after buying an additional 3,736 shares during the period. Finally, Allworth Financial LP increased its position in shares of Fresenius Medical Care by 53.1% in the third quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock worth $36,000 after acquiring an additional 581 shares in the last quarter. Institutional investors own 8.37% of the company’s stock.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.